The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. WARNING: Important safety information is provided in a boxed warning ...
Adenuric(R) Represents the First Major Treatment of Gout for More Than Forty Years Regulatory News: Ipsen (Paris:IPN) announced today that the Committee for Medicinal Products for Human Use (CHMP) of ...
Ipsen stands to earn roughly $197 in up-front and success-based fees. Menarini negotiated exclusive rights to Ipsen’s EMEA-approved gout therapy, Adenuric®, in 41 countries including those in the EU, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results